Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.
The materials will be used for the production of clear aligners.
The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.